---
layout: default
title: Clinical Experience
nav_order: 1
---

# Clinical Research Experience

[Download Therapeutic Areas Summary](../assets/therapeutic-areas-summary.pdf)

## Therapeutic Areas

### 1. Oncology
- **Project Experience**:
  - Phase III randomized controlled trial in NSCLC (N=336)
  - Biomarker sub-study in NSCLC using NGS data
- **Key Methodologies**:
  - Survival analysis (Kaplan-Meier, Cox PH models)
  - Tumor response evaluation (RECIST 1.1)
  - Time-to-event endpoints (PFS, OS)

### 2. Chronic Kidney Diseases
- **Project Experience**:
  - Real World Study & Pragmatic Clinical Trials 
  - 
  - 
- **Key Methodologies**:
  - Longitudinal data analysis
  - Propensity score matching
  - Composite endpoint evaluation

### 3. Womenâ€™s Health
- **Project Experience**:
  - Fezolinetant in vasomotor symptoms associated with Menopause
  - Phase II dose-finding study and Phase IIIlong term safety
  - 
- **Key Methodologies**:
  - Mixed models for repeated measures

### 4. Rare Disease
- **Project Experience**:
  - DMD with electronic wearable devices and qualitative assessment
  - Phase I
- **Key Methodologies**:
  - Cognitive assessment scoring
  - Missing data imputation

### 5. Infectious Diseases
- **Project Experience**:
  - Predicting CLABSI using EHR data (retrospective observational study)
  - Antimicrobial resistance patterns
  - COVID-19 treatment outcomes
- **Key Methodologies**:
  - Identifying CLABSI using automation algorithm for surveillance of infection
  - Dynamic prediction using landmark approach
  - Assess model performance using discrimnation, calibration and clinical utility

## Clinical Trial Expertise

### Trial Design
